T2D type 2 diabetes, iAUC incremental area under the curve, tAUC total area under the curve, IGI insulinogenic index, HOMA2-B homeostasis model assessment for -cell function, HOMA2-IR homeostasis model assessment for insulin resistance, HOMA2-S homeostasis model assessment for insulin sensitivity, OGIS oral glucose insulin sensitivity
On the gastrointestinal front, literature has described mucosal barrier protection via modulation of endogenous prostaglandin (PGE2) and heat shock proteins (HSP70/90)
It generally offers excellent symptom resolution but carries risks like bleeding, adhesions, and fibroid recurrence, which can occur in about 15-30% of cases
There are potential drawbacks to the short-term program, however
Around 30% of adherent participants achieved at least a 20% reduction in body weight